Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour ; day:22 ; month:8 ; year:2023 ; pages:1-19
Cellular oncology ; (22.8.2023), 1-19
- Urheber
-
Zhang, Hanzhao
Konjusha, Dardan
Rafati, Nima
Tararuk, Tatsiana
Hallböök, Finn
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13402-023-00863-0
- URN
-
urn:nbn:de:101:1-2023110608493514201675
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Hanzhao
- Konjusha, Dardan
- Rafati, Nima
- Tararuk, Tatsiana
- Hallböök, Finn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene
Regulation der Genexpression von MYCN in humanen Neuroblastomzellen durch Transkriptionsfaktoren der E2F-Familie
Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
Neue Zielgene des Transkriptionsfaktors E2F-1 und die transkriptionelle Regulation des MYCN-Onkogens im humanen Neuroblastom
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Retinoblastoma
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
RB1-Promotormethylierung bei Glioblastomen
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene
Regulation der Genexpression von MYCN in humanen Neuroblastomzellen durch Transkriptionsfaktoren der E2F-Familie
Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
Neue Zielgene des Transkriptionsfaktors E2F-1 und die transkriptionelle Regulation des MYCN-Onkogens im humanen Neuroblastom
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Retinoblastoma
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
RB1-Promotormethylierung bei Glioblastomen
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene
Regulation der Genexpression von MYCN in humanen Neuroblastomzellen durch Transkriptionsfaktoren der E2F-Familie
Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
Neue Zielgene des Transkriptionsfaktors E2F-1 und die transkriptionelle Regulation des MYCN-Onkogens im humanen Neuroblastom
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Retinoblastoma
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma